Related Experiment Video
Updated: Apr 14, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Frailty in inflammatory bowel disease: a missing link in personalized care for the aging IBD population
Guillaume Le Cosquer1,2, Cyrielle Gilletta1, Bharati Kochar3
1Department of Gastroenterology and Pancreatology, Toulouse University Hospital, Rangueil Hospital, 31059, Toulouse, France.
Background:
Frailty is a potentially reversible condition that reflects decreased physiological reserve and is increasingly recognized in older patients with inflammatory bowel disease (IBD). Although frailty is frequently associated with advanced age, multi-morbidity, and disease severity, this condition represents a distinct clinical syndrome with independent prognostic significance that warrants dedicated assessment.
Methods:
We performed a narrative review of studies exploring frailty in patients with IBD, focusing on definitions, prevalence, assessment tools, clinical implications, and interventions.
Results:
Two main conceptual models of frailty have been applied to IBD: the phenotypic model, an individual-level assessment defining frailty as a syndrome; and the cumulative deficit model, which is suited for retrospective identification. While eleven frailty tools have been used in IBD studies, none were specifically designed or validated for the IBD patient population. Owing to heterogeneous definitions and populations, the reported prevalence of frailty in IBD patients ranges from 6% to 62%. Frailty is associated with increased risks of hospitalization, prolonged hospitalization, postoperative complications, infections, and mortality. Key drivers of frailty in IBD include fatigue, sarcopenia, and malnutrition, common features of IBD that may share mechanisms. While these factors contribute to frailty, the syndrome itself independently predicts adverse clinical outcomes. Current limitations include heterogeneous definition, underrepresentation of older patients, lack of longitudinal data, and absence of IBD-specific tools.
Conclusions:
Frailty is a critical, under-recognized determinant of poor outcomes in IBD. Systematic screening and integration into care pathways could improve patient stratification and management. Future research should aim to validate specific assessment tools and test interventions to ameliorate frailty in older IBD patients.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

